BIOVENTIX
LIVE

Serial Number

98560610

Owner

Bioventix PLC

Attorney

Christopher D. Casavale

Filing Date

May 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIOVENTIX Trademark

Serial Number: 98560610 • Registration: 8113369

BIOVENTIX is a trademark filed by Bioventix PLC on May 21, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bioventix PLC

27-28 Eastcastle Street
London W1W8DH , GB

Entity Type: 99

Trademark Details

Filing Date

May 21, 2024

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Chemicals preparations for use in industry, science and photography, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticide; antibody reagents used for detection of antigens in cells and tissue, other than for medical or veterinary purposes; monoclonal antibody reagents, other than for medical or veterinary purposes; monoclonal antibodies for scientific purposes; Chemical preparations, namely, radio-labelled monoclonal antibody for industrial or scientific use and not for medical or veterinary purposes; Chemical preparations, namely, radio-labelled monoclonal antibody for industrial or scientific use for medical or diagnostic purposes; reagents for scientific and research use, namely, reagents for development of monoclonal antibodies other than for medical or veterinary purposes

Sanitary preparations for medical purposes; antibodies for medical purposes; antibody fragments for medical purposes; antibody reagents used for detection of antigens in cells and tissue, for medical and diagnostic purposes; antibodies and antibody fragments for medical and veterinary diagnostics; antibodies and antibody fragments for use in the discovery, preclinical and clinical development of medical therapeutic products; biological indicators for use in medical diagnosis of diseases, deficiencies, organ disease and disfunction, cancer, fertility issues, for medical purposes ; reactants for use in medical diagnosis, in the nature of substances or compounds that can facilitate a reaction for use in medical tests, for use in medical diagnosis of diseases, deficiencies, organ disease and disfunction, cancer, fertility issues, for medical purposes; medical reagents for use in the development of monoclonal antibodies for medical purposes; veterinary reagents for use in the development of monoclonal antibodies for veterinary purposes; diagnostic reagents for medical diagnostics and medical use, veterinary diagnostics and veterinary use, clinical diagnostics and clinical use and chemical testing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 7, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 30, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 30, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 31, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 31, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 31, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 5, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 24, 2024 NWOS
NEW APPLICATION ENTERED
May 21, 2024 NWAP